<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Infect Dis Obstet Gynecol</journal-id><journal-title>Infectious Diseases in Obstetrics and Gynecology</journal-title><issn pub-type="ppub">1064-7449</issn><issn pub-type="epub">1098-0997</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">15108863</article-id><article-id pub-id-type="pmc">1852293</article-id>
            <article-id pub-id-type="pii">S1064744903000280</article-id>
            <article-id pub-id-type="doi">10.1080/10647440300025519</article-id>
      <article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>The Efficacy of Vaginal Clindamycin for the Treatment of
Abnormal Genital Tract Flora in Pregnancy</article-title></title-group><contrib-group>
            <contrib contrib-type="author" corresp="yes"><name><surname>Lamont</surname><given-names>Ronald F.</given-names></name><address><email>pauline.mills@nwlh.nhs.uk</email></address><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref></contrib>
            <contrib contrib-type="author"><name><surname>Jones</surname><given-names>Brian M.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib>
            <contrib contrib-type="author"><name><surname>Mandal</surname><given-names>Debashis</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib>
            <contrib contrib-type="author"><name><surname>Hay</surname><given-names>Philip E.</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib>
            <contrib contrib-type="author"><name><surname>Sheehan</surname><given-names>Marie</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib>
      </contrib-group>
            <aff id="aff1"><label>1</label>
                <addr-line>Northwick Park and St Mark's NHS Trust</addr-line>
                <addr-line>Harrow</addr-line>
                <addr-line>Middlesex</addr-line>
                <country>United Kingdom</country>
            </aff>
            <aff id="aff2"><label>2</label>
                <addr-line>University of Sheffield</addr-line>
                <addr-line>Sheffield</addr-line>
                <country>United Kingdom</country>
            </aff>
            <aff id="aff3"><label>3</label>
                <addr-line>Manchester Centre for Sexual Health</addr-line>
                <addr-line>Manchester Royal Infirmary</addr-line>
                <addr-line>Manchester</addr-line>
                <country>United Kingdom</country>
            </aff>
            <aff id="aff4"><label>4</label>
                <addr-line>St George's Hospital</addr-line>
                <addr-line>Tooting</addr-line>
                <addr-line>London</addr-line>
                <addr-line> SW17</addr-line>
                <country>United Kingdom</country>
            </aff>
            <aff id="aff5"><label>5</label>
                <addr-line>Imperial College School of Science</addr-line>
                <addr-line>Technology and Medicine</addr-line>
                <addr-line>London</addr-line>
                <country>United Kingdom</country>
            </aff>
            <aff id="aff6"><label>6</label>
                <addr-line>Department of Obstetrics and Gynaecology</addr-line>
                <addr-line>Northwick Park and St Mark's NHS Trust</addr-line>
                <addr-line>Watford Road</addr-line>
                <addr-line>Harrow, Middlesex</addr-line>
                <addr-line>London</addr-line>
                <addr-line>HA1 3UJ</addr-line>
                <country>United Kingdom</country>
            </aff>
            <pub-date pub-type="ppub"><year>2003</year></pub-date><volume>11</volume><issue>4</issue><fpage>181</fpage><lpage>189</lpage><history><date date-type="received"><day>29</day><month>10</month><year>2002</year></date><date date-type="accepted"><day>16</day><month>7</month><year>2003</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2003 Hindawi Publishing Corporation.</copyright-statement><copyright-year>2003</copyright-year><copyright-holder>Hindawi Publishing Corporation</copyright-holder><license license-type="open-access" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by/"><p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract>
        <p><italic>Objective:</italic> To assess the efficacy of 2% clindamycin vaginal cream (CVC) to treat bacterial vaginosis (BV) in
              pregnancy.</p>
<p><italic>Methods:</italic> A prospective, randomized, double-blind, placebo-controlled, tricenter study. Four hundred and four
women with BV on Gram stain at their first antenatal clinic visit were randomized to receive a 3-day course of
2% CVC or placebo. The outcome was assessed using an intention to treat analysis at 3 weeks and 6 weeks
post-treatment according to three different diagnostic methods based on five criteria (Gram stain and all four
elements of clinical composite criteria: vaginal discharge, abnormal vaginal pH, clue cells, amine odor), three
criteria (vaginal pH, clue cells, amine odor) or two criteria (clue cells and amine odor) to reflect stringency of
diagnosis, historical precedence and government agency recommendations respectively.</p>
<p><italic>Results:</italic> Using five diagnostic criteria, 18% of CVC patients were cured and 70.8% either cured and/or improved
compared to 1.6% and 12% of placebo patients respectively (<italic>p</italic> &#x0003c; 0.0001). Using three diagnostic criteria, 44.8%
of CVC patients were cured and 77.3% were either cured and/or improved compared to 9.3% and 28.8% of
placebo patients respectively (<italic>p</italic> &#x0003c; 0.0001). Using two diagnostic criteria, 75.0% of CVC patients were cured
compared to 18.0% of placebo patients (p &#x0003c; 0.0001). Recurrence rates in those CVC patients successfully treated
were approximately 6% at 6 weeks post baseline and 10% at 28 to 34 weeks gestation.</p>
<p><italic>Conclusions:</italic>  A 3-day course of CVC appears to be well tolerated by the mother and statistically significantly
more efficacious than placebo in the treatment of BV during the second trimester of pregnancy.</p>
                        </abstract></article-meta></front></article>


